 |
PDBsum entry 5glj
|
|
|
|
References listed in PDB file
|
 |
|
Key reference
|
 |
|
Title
|
 |
High-Resolution crystal structure of the pdz1 domain of human protein tyrosine phosphatase ptp-Bas.
|
 |
|
Authors
|
 |
S.O.Lee,
M.K.Lee,
B.Ku,
K.H.Bae,
S.C.Lee,
H.M.Lim,
S.J.Kim,
S.W.Chi.
|
 |
|
Ref.
|
 |
Biochem Biophys Res Commun, 2016,
478,
1205-1210.
[DOI no: ]
|
 |
|
PubMed id
|
 |
|
 |
 |
|
Abstract
|
 |
|
Protein tyrosine phosphatase-Basophil (PTP-Bas) is a membrane-associated protein
tyrosine phosphatase with five PDZ domains and is involved in apoptosis,
tumorigenesis, and insulin signaling. The interaction between PTP-Bas and
tandem-PH-domain-containing protein 1/2 (TAPP1/2) plays an essential role in the
regulation of insulin signaling. Despite its high sequence homology with the
other PDZ domains, only the PDZ1 domain of PTP-Bas showed distinct binding
specificity for TAPP1/2. Although the interaction between PTP-Bas PDZ1 and
TAPP1/2 is a therapeutic target for diabetes, the structural basis for the
interaction has not been elucidated. In the present study, we determined the
crystal structure of the PTP-Bas PDZ1 domain at 1.6 Å resolution. In addition,
we calculated the structural models of complexes of PTP-Bas PDZ1 and the
C-terminal peptides of TAPP1/2 (referred to as TAPP1p/2p). Structural comparison
with the PTP-Bas PDZ2/RA-GEF2 peptide complex revealed a structural basis for
distinct binding specificity of PTP-Bas PDZ1 for TAPP1p/2p peptides. Our
high-resolution crystal structure of PTP-Bas PDZ1 will serve as a useful
template for rational structure-based design of novel anti-diabetes therapeutics.
|
 |
|
|
|
|
 |